TrialAntimicrobial agents and chemotherapy2012

First-in-human study of the pharmacokinetics and antiviral activity of IDX375, a novel nonnucleoside hepatitis C virus polymerase inhibitor.

J de Bruijne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.